Lucie Bourguignon is a PhD student studying at the Machine Learning and Computational Biology Lab in ETH Zurich, under the supervision of Dr. Catherine Jutzeler. She holds a Bachelor’s degree in Human Medicine from the University of Bordeaux, a Master’s degree in Computational Biology and Bioinformatics from ETH Zurich and is a MD-PhD candidate at the Ecole de l’INSERM Liliane Bettencourt in Paris.
Ms Bourguignon is interested in working at the intersection between data science and medicine, focused on neurological diseases. In particular, she is interested in data-driven recovery prediction following spinal cord injury.
Ms Bourguignon’s abstract entitled ”Trauma-induced perturbations of serological markers” was accepted for an oral presentation at ISCoS 2021. She will present the evolution of common serological markers over the course of the year following spinal trauma. Those biological markers were studied under the hypothesis that they could reflect the severity and track recovery following the initial injury. Ms Bourguignon and her colleagues have also developed an online interactive and publicly available platform to explore and visualise the data studied. They envisage the haemosurveillance platform as a tool promoting the translation of research findings into clinical applications.
Lucie shares her experiences from the conference.
“Thanks to the SRI travel grant, I was able to attend and participate in the ISCOS conference for the first time this year. It was a great opportunity for me to share early results from my PhD work, where I studied trauma-induced perturbations in serological markers after traumatic spinal cord injuries. Receiving feedback from the rest of the research community was very encouraging. Additionally, participating in the conference allowed me to learn more about the other areas of spinal cord injury research, including ongoing clinical trials and fundamental biological research. I had previously encountered those topics mainly through my readings and was glad to (virtually) meet with the researchers who impulsed them, such as Dr. Charles H. Tator and Dr. Michael G. Fehlings. The SRI travel grant also gave me an additional opportunity to meet more directly with researchers from all around the world, which was definitely the highlight of the online conference experience. Altogether, I realise through the conference that improving health outcomes for people with SCI requires research in multiple domains and active collaborations between them, and this is what both the ISCoS conference organisation and the SRI travel grant are promoting.”